Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. GILD
GILD logo

GILD

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GILD News

Entergy Partners with Meta, Stock Surges Over 8%

3d agoCNBC

AstraZeneca's Drug Trial Shows Promising Results

3d agoCNBC

Novartis Plans $2 Billion Acquisition of Excellergy for Allergy Treatment

3d agoCNBC

Gilead to Acquire Ouro Medicines for $2.18B, Expanding Inflammation Pipeline

3d agoYahoo Finance

Weave Bio Forms Strategic Advisory Board to Enhance AI in Regulatory Processes

5d agoYahoo Finance

AVLV Stock Price Analysis and ETF Dynamics

6d agoNASDAQ.COM

Tesla Sees Sales Rebound in Europe and China

6d agoFool

Gilead Acquires Ouro to Enhance Portfolio

6d agoFool

Gilead Acquires Ouro Medicines for $2.2 Billion, Targeting Future Stock Growth with Key Therapy.

6d agoBarron's

Stock Market Movers: Tesla, Jefferies, Apollo, Gilead, Estée Lauder, and Others

6d agoBarron's

Galapagos in Advanced Talks for Strategic Collaboration with Gilead

6d agoYahoo Finance

Gilead Acquires Ouro Medicines to Enhance Portfolio

6d agoNASDAQ.COM

Gilead Acquires Ouro Medicines for $1.675 Billion, Expanding Inflammation Portfolio

6d agoseekingalpha

Gilead Acquires Ouro Medicines for $1.675 Billion in Cash

6d agoYahoo Finance

Gilead Acquires Ouro Medicines to Enhance Inflammation Portfolio

6d agoNewsfilter

GILEAD: OURO MEDICINES TO RECEIVE AS MUCH AS $500 MILLION IN CONDITIONAL MILESTONE PAYMENTS

6d agomoomoo